Dyne Therapeutics Inc (DYN)
NASDAQ
News
Market Data
Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
The current DYN market cap is 3.48B. The company's latest EPS is USD -2.3500 and P/E is -14.72.
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -66.74M | -62.27M | -67.69M | -69.16M | -71.96M |
| Net Income | -64.9M | -60.21M | -66.64M | -65.65M | -65.1M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -13.83M | -58.65M | -150.03M | -170.96M | -242.16M |
| Net Income | -14.86M | -59.44M | -149.29M | -168.1M | -235.94M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 251.42M | 205.24M | 165.08M | 522.28M | 825.88M |
| Total Liabilities | 44.54M | 53.21M | 73.79M | 44.22M | 50.69M |
| Total Equity | 206.88M | 152.04M | 91.29M | 478.06M | 775.19M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 16.44M | 353.33M | 425.66M | 306.33M | 165.08M |
| Total Liabilities | 2.4M | 10.97M | 57.47M | 53.96M | 73.79M |
| Total Equity | 14.04M | 342.37M | 368.2M | 252.36M | 91.29M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -102.55M | -153.15M | -188.16M | -78.54M | -133.41M |
| Investing | 44.29M | 57.12M | 83.31M | -179.84M | -168.66M |
| Financing | 53.72M | 54.18M | 54.32M | 408.39M | 788.25M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -11.83M | -46.51M | -119.56M | -153.65M | -188.16M |
| Investing | -1.65M | -45.66M | -137.89M | 87.2M | 83.31M |
| Financing | 19.99M | 380.69M | 157.82M | 37.39M | 54.32M |
| Market Cap | 3.48B |
| Price to Earnings Ratio | -14.72 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 28.56 |
| Price to Book Ratio | 38.05 |
| Dividend Yield | - |
| Shares Outstanding | 100.4M |
| Average Volume (1 week) | 1.79M |
| Average Volume (1 Month) | 1.95M |
| 52 Week Change | 280.76% |
| 52 Week High | 47.45 |
| 52 Week Low | 6.40 |
| Spread (Intraday) | 0.14 (0.4%) |
| Company Name | Dyne Therapeutics Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.dyne-tx.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
